Filter
362
Filtered Results: 362
Text search:
USAID,
Stop
TB
Partnership
Featured
Recommendations
32
New Publications
142
Language
Document type
No document type
302
Studies & Reports
22
Guidelines
19
Manuals
8
Strategic & Response Plan
6
Training Material
2
Fact sheets
2
Brochures
1
Countries / Regions
Kenya
20
Nepal
13
Western and Central Europe
12
Bangladesh
12
Malawi
10
Tanzania
10
Uganda
10
Zambia
10
India
10
Cambodia
9
Eastern Europe
9
Ethiopia
9
Rwanda
8
Myanmar / Burma
8
Namibia
7
Nigeria
6
Philippines
5
Mozambique
5
Asia
5
Latin America and the Carribbean
5
South Africa
5
Ghana
4
Sierra Leone
4
Indonesia
4
Liberia
4
Lesotho
3
Global
3
Pakistan
3
Ukraine
2
Africa
2
Congo, Democratic Republic of
2
South–East Asia Region
2
Botswana
2
Timor Leste/ East Timor
1
Thailand
1
Benin
1
Cameroon
1
Albania
1
Laos
1
Senegal
1
Afghanistan
1
Peru
1
Zimbabwe
1
Guinea
1
Middle East and North Africa
1
Vietnam
1
Brazil
1
Sri Lanka
1
Central African Republic
1
Bhutan
1
South Sudan
1
Iraq
1
Madagascar
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
83
Policies
38
Studies & Reports
29
TB
16
Community Health
14
Demograhic Health Surveys DHS
8
Guidelines
7
Women & Child Health
7
Capacity Building
6
Statistics
6
Bacteriology
4
Community Health
3
Countries
3
Reproductive Health
3
Disaster Preparedness
2
Public Health
2
Pediatrics
2
Clinical Guidelines
2
Drugs & Medical Equipment
2
Immunization
2
Women & Child Health
2
Family Planning
1
Humanitarian Aid
1
COVID-19
1
Virology
1
Vaccine-preventable Diseases
1
Health System Strengthening
1
Disabilities
1
Humanitarian Crisis
1
Other
1
Waste Management
1
Communicable Diseases
1
Gynaecology & Obstetrics
1
NTDs & Others
1
Nutrition
1
Primary Health Care
1
HIV & STI
1
Disease Prevention & Control
1
Global Health
1
Toolboxes
Prevention & Control
22
Advocacy & Communication
14
Detection & Diagnosis
12
Drug resistant TB
11
Disease Prevention & Control
9
Reports & Studies
9
Policies & Strategies
8
General
8
TB/HIV Coinfection
8
SEAR (South-east Asia Region)
7
Childhood TB
6
Latin America & the Carribean
5
Eastern Europe & Central Asia
5
TB & Drug Abuse
4
Children
4
Reports
4
Training
4
AmR (Region of Americas)
4
South-east Asia Region
4
Lobby and Advocacy
4
HIV in Key Populations
4
Eastern Europe and central Asia
4
Moldova
3
Children & Adolescents
3
Policies
3
National Policies
3
HIV
3
TB & Other Vulnerable Populations
3
Global Impact: Socio-economic, health services, TB & HIV
3
TB/COVID-19
3
Health Financing Toolbox
3
Malawi
3
TB & Prisoners
3
Research & Access
3
Kenya
3
Biosafety
2
General Reports
2
Clinical Aspects, Treatment & Prevention
2
Treatment & Prevention
2
Adults
2
South Africa
2
Drug resistance
2
Workplace
2
TB/HIV
2
Rational use of Medicine
2
HIV &TB
2
Health Worker
2
General Information & Methodology
2
General
2
Policies and guidelines
2
Ghana
2
TB/HIV Global
2
Uganda
2
Nigeria
2
Clinical Guidelines
2
Western & Central Europe
2
Antiretroviral Treatment ART
2
Behaviour Change/Life Skill Education
1
Assessment & Studies
1
HIV support organizations
1
HIV testing & services
1
Azerbaijan
1
Policies & Strategies
1
Clinical Aspects
1
Ukraine
1
Assessment & Response
1
Children
1
Eastern Mediterranean Region
1
Transgender People
1
Namibia
1
Public Health
1
Communication & Training
1
IEC Materials
1
People who injecting Drugs
1
IEC Materials
1
Rwanda
1
African Region
1
Discrimination & Stigma
1
Advocacy
1
Georgia
1
Sex Worker
1
Toolkit on disability for Africa
1
Diagnostics & Laboratory Guidance
1
Waste Management
1
Others
1
Overview
1
Peru
1
Overview & reports
1
Essential Medicines
1
Prices and Patents
1
General Guidelines for Rational Use
1
Waste Managment
1
Best Practice Examples
1
West and central Africa
1
Access to treatment and laboratory
1
Education
1
Women
1
Armenia
1
Romania
1
Asia and Pacific
1
Botswana
1
General
1
General Aspects
1
Assessment & Response
1
Regional Reports & Guidelines, others
1
For Community Health Workers
1
AR (African Region)
1
Tuberculosis
1
Nutrition
1
Dengue Prevention & Control
1
HIV / AIDS
1
HIV and coinfection
1
Others
1
Global Health Institutions and Stakeholders
1
MHPSS Guidelines
1
Prisoners
1
KNCV Tuberculosis Foundation - Your Partner in the fight against TB
Accessed November 2017
This guidance is intended for use in developing standalone TB strategic plans, or TB interventions as part of multidisease or health sector plans. It describes key considerations and steps for strategic planning for TB in line with the World Health Organization’s End TB strategy, and the proposed ...
Ciudad de México, México - 26 al 28 de mayo del 2014
The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for a robust national response that can accelerate prog...
Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat...
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children who are in contact with infectious TB cases (through implementation of active contact investigation and provision of preventive treatment); an...
This publication offers practical advice on implementing HIV and STI programmes for transgender people, with a focus on transgender women, aligned with the 2011 Recommendations and the 2014 Key Populations Consolidated Guidelines. It contains examples of good practice from around the world that may ...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Framework for implementation.
The END TB Strategy.
The SAARC Member States have more than an estimated 2.0 million TB cases accounting for close to one-third of the total cases of TB in the world. India alone had almost one-fifth of the global disease burden due to TB. India, Pakistan and Bangladesh followed by Afghanistan are the major contributors...
Undernutrition increases the risk of tuberculosis (TB) and in turn TB can lead to malnutrition. Undernutrition is therefore highly prevalent among people with TB. It has been demonstrated that undernutrition is a risk factor for progression from TB infection to active TB disease and that undernutrit...
6 July 2021. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included.
The latest operational handbook includes the new classes recommended by WHO. It aims at facilitating the implementation of the WHO recommendations by the Member States, technical partners, and ot...
Tuberculosis cases, TB deaths
The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
